ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Donor Specific Antibody (DSA) Does Not Predict Inflammation, Fibrosis, or C4d Score in 12 Tolerant Pediatric Liver Transplant (LT) Recipients: 5+Year Longitudinal Follow-Up

    S. Feng, U. Ekong, A. Demetris, P. Rosenthal, E. Alonso, S. Kanaparthi, Z. Gao, N. Tchao

    UCSF, San Francisco, CA; Northwestern U, Chicago, IL; U Pittsburgh, Pittsburgh, PA; ITN, Bethesda, MD

    BACKGROUND ITN029, a multicenter pilot trial (n=20) of immunosuppression withdrawal (ISW) in pediatric recipients of parental living donor LTs, identified 12 tolerant participants (pts). The…
  • 2013 American Transplant Congress

    Subnormothermic Ex Vivo Liver Perfusion (SNEVLP) Reduces Ischemia/Reperfusion Injury in Livers Retrieved after Cardiac Death

    J. Knaak, M. Boehnert, V. Spetzler, B. Kim, K. Louis, C. Eid, N. Selzner, A. Oyedele, P. Yip, S. Keshavjee, D. Grant, M. Selzner

    Multiorgan Transplant, University Health Network, Toronto, ON, Canada; Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada; Pathology, University Health Network, Toronto, ON, Canada; Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada

    We compared the impact of cold static liver preservation vs subnormothermic ex vivo liver perfusion (SNEVLP) on outcome of DCD pig liver transplantation (LT). Methods:…
  • 2013 American Transplant Congress

    Long Term Outcomes of Treatment for Vascular Complication Following Living Donor Liver Transplantation: The Efficacy of Stent Placement

    S. Mizuno, K. Yamakado, A. Tanemura, N. Kuriyama, I. Ohsawa, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, M. Tabata, H. Sakuma, S. Isaji

    Hepatobiliary Pancreatic Transplant Surgery, Mie Univeristy, Tsu, Japan; Radiology, Mie Univeristy, Tsu, Japan

    Background: Vascular complication after liver transplantation sometimes leads to graft loss. The aims of this study were to evaluate the efficacy of stent placement for…
  • 2013 American Transplant Congress

    Influence of HLA Class II Donor-Specific Antibodies Present at the Time of Renal Transplantation on Early Graft Outcome, The

    C. Bryan, A. Gupta, D. Murillo, C. Wang, S. Yarlagadda, A. Nawabi, T. Schmitt

    Midwest Transplant Network, Westwood, KS; Kansas University Medical Center, Kansas City, KS; Research Medical Center, Kansas City, MO

    Introduction. HLA class II donor-specific antibodies (DSA's) have been associated with transplant glomerulopathy and ultimate graft loss. Despite these data, it is unclear if all…
  • 2013 American Transplant Congress

    Is Evaluation of Incidental Adrenal Lesions in Living Renal Donors Necessary?

    J. Wang, A. Rastogi, H. Gritsch

    Urology, Shandong Univ. Affiliated Qianfoshan Hospital, Jinan, Shandong, China; Nephrology, Univ. of California, Los Angeles, CA; Urology, Univ.of California, Los Angeles, CA

    Introduction: The purpose of the study was to evaluate the prevalence and significance of incidental adrenal lesions identified in potential living renal donors.Methods: The medical…
  • 2013 American Transplant Congress

    Priority Pass to Death – Prioritization of Liver Transplant for HCC Worsens Survival, A

    K. Halazun, E. Verna, B. Samseitn, J. Guarrera, T. Kato, R. Brown Jr, J. Emond

    Center for Liver Disease And Transplantation, Columbia University Medical Centre, New York, NY

    Background – The current UNOS allocation system gives priority to patients with HCC to receive livers. This can potentially cause significant regional disparities in organ…
  • 2013 American Transplant Congress

    Hyperuricemia Is Associated with Both Histological Alteration in Implant Biopsy and Risk Factor of Donor’s Renal Function Decline after 1-Year in Living-Kidney Transplantation

    K. Tanaka, K. Sakai, T. Nemoto, Y. Ohashi, Y. Tanaka, M. Muramatsu, Y. Hyodo, T. Kawamura, S. Shishido, A. Aikawa

    Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan; Department of Surgical Pathology, School of Medicine, Toho University, Tokyo, Japan

    Objective: Only living donation enables for timely kidney transplantation for patients with end stage renal disease. Donors's follow-up is often neglected, bringing up economic and…
  • 2013 American Transplant Congress

    Effect of Prophylaxis Duration on the Incidence of CMV Viremia and Hospitalization Rates in D+/R- Kidney Transplant Recipients

    J. Sia, J. Westervelt, E. Lyden, C. Miles

    Medicine, Division of Nephrology, University of Nebraska Medical Center, Omaha, NE; Biostatistics, University of Nebraska Medical Center, Omaha, NE

    Purpose: In high-risk CMV kidney transplant recipients, the optimal duration of prophylaxis is unclear. We assessed the rates of CMV viremia and related hospitalization in…
  • 2013 American Transplant Congress

    Decreased Hypertension in Pediatric Transplant Patients Having Undergone Native Nephrectomies

    A. Gallo, C. Gowdy, J. Berumen, A. Chaudhuri, A. Hill, W. Concepcion

    Surgery, Stanford University, Palo Alto, CA

    Background: Native nephrectomy prior to kidney transplantation is performed on pediatric patients for congenital anomalies, proteinuria, intractable hypertension, malignancy and chronic infection. The impact of…
  • 2013 American Transplant Congress

    ES Cell-Derived Hematopoietic Progenitor Cells Downregulate Alloreactive T Cells Using Arginase 1

    E. Kim, B. Miyake, M. Aggarwal, N. Zavazava

    Internal Medicine, University of Iowa, Iowa City, IA; VA Medical Center, Iowa City, IA

    We and others have previously reported that ES cell-derived hematopoietic progenitor cells (ESC-HPCs) induce transplantation tolerance. However the mechanisms by which this process occurs have…
  • « Previous Page
  • 1
  • …
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences